TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32201919

Group type: EXPERIMENTAL
Intervention: Lemon juice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Black tea
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water
Number of subjects: 0

Group type: COMPARATOR
Intervention: None of the tested beverages
Number of subjects: 0
Study: 36480397

Group type: EXPERIMENTAL
Intervention: Abstinence
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Reduced drinking (1-3 WHO drinking risk levels without abstinence)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Nonreduced drinking (maintained or increased drinking risk level)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Overall outcomes
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Psychological and functional outcomes
Number of subjects: 241
Study: 34315697

Group type: EXPERIMENTAL
Intervention: Stepwise-hierarchical pooled analysis method
Number of subjects: 0
Study: 32619524

Group type: EXPERIMENTAL
Intervention: High dose intravenous (IV) thiamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35459114

Group type: EXPERIMENTAL
Intervention: High-intensity hardstyle kettlebell training
Number of subjects: 32
Study: 33875487

Group type: EXPERIMENTAL
Intervention: GLP-1RA
Number of subjects: 16690

Group type: COMPARATOR
Intervention: DPP-4I
Number of subjects: 16690
Study: 35435039

Group type: EXPERIMENTAL
Intervention: Curcumin (4 g twice daily from 2 days before melphalan until day +28) along with standard supportive care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard supportive care)
Number of subjects: 40
Study: 36213563

Group type: EXPERIMENTAL
Intervention: Oral implant restoration
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional dentition restoration
Number of subjects: 118
Study: 34173380

Group type: EXPERIMENTAL
Intervention: Nurse-driven HIV screening offered to key populations in EDs
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Nurse-driven HIV screening
Number of subjects: 218
Study: 32286659

Group type: COMPARATOR
Intervention: Tailored BBTI
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard BBTI
Number of subjects: 92
Study: 36091017

Group type: EXPERIMENTAL
Intervention: Renin-angiotensin system inhibitors (RASi) at maximum tolerant dose for 3 months
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Hub gene validation using real-time quantitative polymerase chain reaction (qRT-PCR)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) curve analysis
Number of subjects: 370
Study: 33509504

Group type: EXPERIMENTAL
Intervention: Soybean oil
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Extra virgin olive oil
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Coconut oil
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 52
Study: 34168292

Group type: EXPERIMENTAL
Intervention: High protein formula (Fresubin® Intensive; HPG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Contemporary matched conventional therapy group (CTG)
Number of subjects: 18
Study: 33413307

Group type: EXPERIMENTAL
Intervention: Elderly display condition
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: High-FSA-J group
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 123
Study: 33070144

Group type: EXPERIMENTAL
Intervention: Topical cidofovir (first-line therapy)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Topical foscavir (first-line therapy)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous foscavir (first-line therapy)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Topical cidofovir (second-line therapy)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Topical foscavir (second-line therapy)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Intravenous foscavir (second-line therapy)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 6
Study: 36207701

Group type: EXPERIMENTAL
Intervention: CAD system
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 154
Study: 34610099

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (intermittent manual assistance)
Number of subjects: 100
Study: 32927609

Group type: EXPERIMENTAL
Intervention: Adherence to the Mediterranean diet (AMedDiet)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Maximal aerobic power (Vo2max)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: New formula for predicting SBP
Number of subjects: 62
Study: 36153555

Group type: EXPERIMENTAL
Intervention: Digital format of the German schizophrenia guideline using MAGICapp
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic print pdf version of the German schizophrenia guideline
Number of subjects: 0
Study: 34541941

Group type: EXPERIMENTAL
Intervention: Glucose-free dialysate
Number of subjects: 66

Group type: COMPARATOR
Intervention: Glucose-containing dialysate (5.55 mmol/L)
Number of subjects: 66
Study: 35104042

Group type: EXPERIMENTAL
Intervention: Topical turmeric cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 30
Study: 32647961

Group type: EXPERIMENTAL
Intervention: Experimental group (180 subjects consisting of 90 males and 90 females) using combined CBCT and 3dMD photogrammetry system
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Experimental group (180 subjects)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Test group (60 subjects consisting of 30 males and 30 females)
Number of subjects: 240
Study: 35227940

Group type: EXPERIMENTAL
Intervention: IR/ER-amantadine 193 mg
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: IR/ER-amantadine 258 mg
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 33342523

Group type: EXPERIMENTAL
Intervention: Treatment schools with access to free breakfast, lunch, and supper on school days, and a food backpack on weekends and school breaks
Number of subjects: 2636

Group type: COMPARATOR
Intervention: Control schools with a less robust set of benefits
Number of subjects: 2636
Study: 35879482

Group type: EXPERIMENTAL
Intervention: Arginine-enriched supplements (AES)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isocaloric/isonitrogenous control supplement
Number of subjects: 24
Study: 33494640

Group type: EXPERIMENTAL
Intervention: Leptospirosis
Number of subjects: 3699

Group type: EXPERIMENTAL
Intervention: Leptospirosis in males
Number of subjects: 3699

Group type: EXPERIMENTAL
Intervention: Leptospirosis in individuals aged 18-39
Number of subjects: 3699

Group type: EXPERIMENTAL
Intervention: Leptospirosis within first 2 years after diagnosis
Number of subjects: 3699
Study: 35728386

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 68
Study: 32585923

Group type: EXPERIMENTAL
Intervention: Consumer-driven redesign of instructional materials (instruction sheet, swing tags, online training videos)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consumer-driven redesign of instructional materials
Number of subjects: 0
Study: 35656683

Group type: EXPERIMENTAL
Intervention: Honey solution (5 mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sterile water (5 mL)
Number of subjects: 100
Study: 33628967

Group type: EXPERIMENTAL
Intervention: Theory-based intervention (n = 83)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Custom education (n = 83)
Number of subjects: 166
Study: 36193978

Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (HDDT) with esomeprazole 40 mg and amoxicillin 1000 mg three times daily for 14 days
Number of subjects: 658

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (TFEB) with esomeprazole 40 mg, bismuth potassium citrate 220 mg, furazolidone 100 mg twice daily, and tetracycline 500 mg three times daily for 14 days
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (HDDT)
Number of subjects: 658

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (TFEB)
Number of subjects: 658
Study: 32835882

Group type: EXPERIMENTAL
Intervention: Subgingival scaling and root planing (SRP) + tg‐aPDT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Subgingival scaling and root planing (SRP) alone
Number of subjects: 40
Study: 35987013

Group type: EXPERIMENTAL
Intervention: Clonazepam (0.5 mg twice daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33119363

Group type: EXPERIMENTAL
Intervention: Measurement-based care
Number of subjects: 2363

Group type: EXPERIMENTAL
Intervention: Person-centered care
Number of subjects: 2363
Study: 32759251

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) at a dose of 30 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36278336

Group type: EXPERIMENTAL
Intervention: Sling exercise therapy (SET) for 4 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (normal activities of daily living)
Number of subjects: 25
Study: 33960674

Group type: EXPERIMENTAL
Intervention: 0.9% saline irrigation twice daily using a 250-ml squeeze bottle in addition to standard treatment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 61
Study: 32787541

Group type: EXPERIMENTAL
Intervention: Active outreach strategies (e.g., tabling in busy areas, attending community events, utilising mixed media, collaborating with clinic staff)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Recruitment strategies involving multiple staff in the field
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Screening and enrolment conducted over 122 trips from June 2015 to December 2018
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Community size
Number of subjects: 314
Study: 33801339

Group type: EXPERIMENTAL
Intervention: Behavioural intervention for weight loss
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: MC4R SNPs rs571312 and rs17782313
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Other SNPs within FTO, TMEM18, SEC16B, BDNF
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Genetic predisposition score (GPS)
Number of subjects: 576
Study: 32333010

Group type: EXPERIMENTAL
Intervention: BCG+OPV vaccination at admission
Number of subjects: 268

Group type: COMPARATOR
Intervention: Usual practice (BCG+OPV vaccination at discharge)
Number of subjects: 268
Study: 34051543

Group type: EXPERIMENTAL
Intervention: Mobile Augmented Reality (MAR) applications
Number of subjects: 122

Group type: COMPARATOR
Intervention: Traditional teaching methods
Number of subjects: 122
Study: 32213473

Group type: EXPERIMENTAL
Intervention: SMS text messaging assessed PHQ-8
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: SMS text messaging assessed PHQ-2
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: SMS text messaging assessed GAD-2
Number of subjects: 206

Group type: COMPARATOR
Intervention: INTW assessed SDS
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: SMS text messaging assessed PHQ-8 and GAD-2
Number of subjects: 206
Study: 36105814

Group type: EXPERIMENTAL
Intervention: Half dose of ChAdOx1 nCoV-19 vaccine
Number of subjects: 16570

Group type: COMPARATOR
Intervention: Full dose of ChAdOx1 nCoV-19 vaccine
Number of subjects: 16570
Study: 34525977

Group type: EXPERIMENTAL
Intervention: VWM-B program
Number of subjects: 0

Group type: COMPARATOR
Intervention: VWM-program (traditional verbal WM training)
Number of subjects: 0
Study: 33616265

Group type: EXPERIMENTAL
Intervention: Use of mechanical lifting aids
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Higher level of education
Number of subjects: 569

Group type: COMPARATOR
Intervention: No intervention reported
Number of subjects: 569
Study: 32297383

Group type: EXPERIMENTAL
Intervention: Unrefined carbohydrate diet with the highest fiber content
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower fiber diets (simple carbohydrate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower fiber diets (unrefined carbohydrate)
Number of subjects: 0
Study: 34210411

Group type: EXPERIMENTAL
Intervention: Optimal Medical Therapy (OMT) defined as at least 1 antiplatelet drug, statin, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and beta-blocker.
Number of subjects: 1472

Group type: COMPARATOR
Intervention: Optimal Medical Therapy (OMT) with ≤2 types of medications.
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: Optimal Medical Therapy (OMT) with 3 types of medications.
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: CABG with individual OMT agents (antiplatelet drug and statin).
Number of subjects: 1472
Study: 32472686

Group type: EXPERIMENTAL
Intervention: Social accountability strategies using community scorecards
Number of subjects: 20
Study: 35604539

Group type: EXPERIMENTAL
Intervention: Subcutaneous ofatumumab 20 mg administered via an autoinjector pen (test formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prefilled syringe (reference formulation)
Number of subjects: 0
Study: 32311968

Group type: EXPERIMENTAL
Intervention: AMBU cervical collar
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Philly cervical collar
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Necklite cervical collar
Number of subjects: 60
Study: 33200296

Group type: EXPERIMENTAL
Intervention: ECL assay
Number of subjects: 2000

Group type: COMPARATOR
Intervention: ELISA assay
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Population PK model
Number of subjects: 2000
Study: 34534317

Group type: EXPERIMENTAL
Intervention: Estradiol (100 µg/24 h)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Estradiol (100 µg/24 h) + Insulin (160 IU)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Insulin (160 IU)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32268795

Group type: EXPERIMENTAL
Intervention: Palliative care intervention (n=33 women, n=42 men)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Palliative care intervention (n=33 women)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Untreated men (control group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Untreated women (control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall comparison of rates of death and rehospitalization
Number of subjects: 150
Study: 34233594

Group type: EXPERIMENTAL
Intervention: Indian classical dance (n=18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Neuromuscular training (n=18)
Number of subjects: 36
Study: 34488241

Group type: EXPERIMENTAL
Intervention: Self-reported basic knowledge of dyslexia
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Self-reported awareness of local tools and processes for identifying dyslexia
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Self-reported attitudes towards engaging in identifying dyslexia
Number of subjects: 705
Study: 32588034

Group type: EXPERIMENTAL
Intervention: High-speed power training (HSPT), 3 times weekly for 8 weeks
Number of subjects: 42
Study: 34537827

Group type: EXPERIMENTAL
Intervention: 1,000+ IU/day vitamin D3
Number of subjects: 688

Group type: COMPARATOR
Intervention: 200 IU/day vitamin D3 (comparison)
Number of subjects: 688
Study: 33267641

Group type: EXPERIMENTAL
Intervention: Fusarium oxysporum f.sp. cubense (Foc) Race 1 isolates VCG 0125 and VCG 01220; characterized using PCR and morphological methods.
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Molecular confirmation of VCGs 0125 and 01220 using specific primer sets for Foc R1.
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis using TEF1-α gene sequences.
Number of subjects: 61
Study: 36360880

Group type: EXPERIMENTAL
Intervention: 10-week functionalistic stress recovery intervention
Number of subjects: 73

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 73
Study: 33203458

Group type: EXPERIMENTAL
Intervention: Pragmatic mobilization intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prescriptive mobilization intervention
Number of subjects: 20
Study: 34505332

Group type: EXPERIMENTAL
Intervention: SMS messages about cardiac arrhythmias sent two times a week for 8 weeks
Number of subjects: 66
Study: 34189934

Group type: EXPERIMENTAL
Intervention: Train-the-trainer approach
Number of subjects: 184

Group type: COMPARATOR
Intervention: Expert training
Number of subjects: 184
Study: 32321083

Group type: EXPERIMENTAL
Intervention: Acceptance and commitment therapy (12 treatment sessions)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 24
Study: 34491388

Group type: EXPERIMENTAL
Intervention: Inulin-type prebiotics for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 32859142

Group type: EXPERIMENTAL
Intervention: p-synephrine (3 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 15
Study: 33198565

Group type: EXPERIMENTAL
Intervention: Cognitive demands (CD) during static stance tasks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Postural demands (PD) in three positions: feet apart, feet together, tandem feet
Number of subjects: 34
Study: 35643561

Group type: EXPERIMENTAL
Intervention: Pre-chop technique using a reverse chopper
Number of subjects: 44

Group type: COMPARATOR
Intervention: Classic stop-and-chop technique
Number of subjects: 44
Study: 33662928

Group type: EXPERIMENTAL
Intervention: Menthol mouth rinse (MEN MR)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo mouth rinse (placebo MR)
Number of subjects: 9
Study: 34196161

Group type: EXPERIMENTAL
Intervention: Group-based high-intensity aerobic interval training (HIAIT)/modified group-based HIAIT intervention (m-Ullevaal)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Moderate continuous training (MICT)
Number of subjects: 120
Study: 34176716

Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 69
Study: 32747200

Group type: EXPERIMENTAL
Intervention: Retzius-sparing approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional anterior transperitoneal approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extraperitoneal approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transperitoneal approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anatomical dissection techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial prostatectomies
Number of subjects: 0
Study: 35710215

Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) + Routine Physical Therapy (RPT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Passive Vertebral Mobilization (PVM) + Routine Physical Therapy (RPT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine Physical Therapy (RPT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Comparison between PVM + RPT and PNF + RPT
Number of subjects: 90
Study: 33078480

Group type: EXPERIMENTAL
Intervention: 30 mg/day crocin for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study: 36067791

Group type: EXPERIMENTAL
Intervention: Honglilai Vaginal Cream (0.625 mg/g) once daily for 3 weeks
Number of subjects: 435

Group type: COMPARATOR
Intervention: Premarin Vaginal Cream (0.625 mg/g) once daily for 3 weeks
Number of subjects: 435
Study: 34801009

Group type: EXPERIMENTAL
Intervention: Trust‐Based Relational Intervention® (TBRI®)
Number of subjects: 360
Study: 34383975

Group type: EXPERIMENTAL
Intervention: Morphine treatment
Number of subjects: 0
Study: 34011197

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 16
Study: 33568163

Group type: EXPERIMENTAL
Intervention: Integrated management model led by information nurses (observation group)
Number of subjects: 1562

Group type: COMPARATOR
Intervention: Control group (before running mode)
Number of subjects: 1562
Study: 33783109

Group type: EXPERIMENTAL
Intervention: Elective metastasectomy
Number of subjects: 481

Group type: COMPARATOR
Intervention: No metastasectomy
Number of subjects: 481
Study: 36205036

Group type: EXPERIMENTAL
Intervention: Interrupted Sitting (3-min of moderate-intensity walking every 30 min for 3 h daily)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (3 h of daily Uninterrupted Sitting)
Number of subjects: 109
Study: 32618875

Group type: EXPERIMENTAL
Intervention: SCS screening trial strategy (TG)
Number of subjects: 105

Group type: COMPARATOR
Intervention: No trial screening strategy (NTG)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: SCS screening trial (TG)
Number of subjects: 105

Group type: COMPARATOR
Intervention: SCS screening trial (TG) vs No trial screening (NTG)
Number of subjects: 105
Study: 34036692

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus pemetrexed-platinum
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo plus pemetrexed-platinum
Number of subjects: 40
Study: 32909468

Group type: EXPERIMENTAL
Intervention: Resistance exercise training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Relaxation control group
Number of subjects: 0
Study: 36137628

Group type: EXPERIMENTAL
Intervention: Smartphone-based care support (SBCS) programme
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 180
Study: 36193755

Group type: EXPERIMENTAL
Intervention: Artificial intelligence-based model using clinical data
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: Artificial intelligence-based model using chest radiographs
Number of subjects: 1356

Group type: EXPERIMENTAL
Intervention: Artificial intelligence-based model using both clinical data and chest radiographs (mixed model)
Number of subjects: 1356
Study: 32037269

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 223

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 223

Group type: COMPARATOR
Intervention: Aspirin/Dipyridamole
Number of subjects: 223
Study: 35508113

Group type: EXPERIMENTAL
Intervention: EEG signals during balance perturbation task
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Convolutional neural network trained on single-trial EEG
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dynamic functional connectivity analysis
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous-time decoding of COP trajectories from EEG using a gated recurrent unit model
Number of subjects: 7